Acquisitions of Businesses (Tables)

12 Months Ended

Dec. 31, 2015

Schedule of Business Acquisitions, by Acquisition

Revenues contributed by the Alent, OMG, Arysta, CAS and Agriphar Acquisitions from the date of each respective acquisition for the years ended December 31, 2015 and 2014 were as follows:



(amounts in millions)	December 31, 2015		December 31, 2014
Alent	$	70.8	$	—
OMG	20.7		—
Arysta	1,197.0		—
CAS	363.0		61.9
Agriphar	181.4		26.1
Total	$	1,832.9	$	88.0

As the integration of the Alent, OMG, Arysta, CAS and Agriphar Acquisitions continues, discrete revenues reported by our existing businesses are being affected by the integration process and are becoming less comparable to prior periods.

The Alent, OMG, Arysta, CAS and Agriphar Acquisitions had net (loss) income for the years ended December 31, 2015 and 2014 as follows:



(amounts in millions)	December 31, 2015			December 31, 2014
Alent	$	(12.4	)	$	—
OMG	(0.4		)	—
Arysta	(86.7		)	—
CAS	(57.9		)	(20.5		)
Agriphar	23.9			(8.3		)
Total	$	(133.5	)	$	(28.8	)

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the consideration transferred and transaction costs incurred to acquire Alent, the OMG Businesses, Arysta, CAS and Agriphar and the amounts of identified assets acquired and liabilities assumed at the acquisition date:



(amounts in millions)	Alent			OMG			Arysta			CAS			Agriphar
Consideration
Cash, net	$	1,507.0		$	236.5		$	2,856.2		$	983.1		$	350.2
Equity Instruments	231.4			—			645.9			52.0			16.6
Long-term debt	—			—			—			—			—
Derivative liability	—			—			—			—			3.5
Total Consideration	$	1,738.4		$	236.5		$	3,502.1		$	1,035.1		$	370.3

Acquisition costs	$	21.1		$	7.0		$	30.2		$	23.6		$	3.2

Identifiable Assets acquired and Liabilities Assumed
Accounts receivable - contractual	$	178.0		$	33.1		$	738.9		$	172.2		$	62.7
- less uncollectible	(1.8		)	(1.6		)	(51.6		)	(18.0		)	(2.6		)
Accounts receivable - fair value	176.2			31.5			687.3			154.2			60.1
Inventories	116.1			13.2			298.0			132.1			42.7
Other current assets	29.3			1.6			126.9			19.1			0.4
Property, plant and equipment	193.0			35.1			123.6			24.8			31.7
Identifiable intangible assets	682.9			77.9			1,773.0			534.0			183.0
Other assets	33.9			0.2			41.0			11.4			4.5
Current Liabilities	(178.6		)	(21.5		)	(581.2		)	(69.7		)	(47.5		)
Non-current deferred tax liability	(139.6		)	(13.6		)	(518.4		)	(26.7		)	(64.9		)
Other long term liabilities	(317.0		)	(4.0		)	(120.4		)	(13.4		)	(9.0		)
Non controlling interest	—			—			(125.2		)	—			—
Total identifiable net assets	596.2			120.4			1,704.6			765.8			201.0

Goodwill	1,142.2			116.1			1,797.5			269.3			169.3

Total purchase price	$	1,738.4		$	236.5		$	3,502.1		$	1,035.1		$	370.3

Business Acquisition, Pro Forma Information

The following unaudited pro forma summary presents consolidated information of the Company as if the Alent, OMG and Arysta Acquisitions had occurred on January 1, 2014:



(amounts in millions)	Year Ended December 31, 2015			Year Ended December 31, 2014
Revenue	$	3,582.4		$	3,559.2
Net (Loss) Income attributable to Stockholders	(328.1		)	(530.8		)

In 2015, the Company incurred $35.9 million of acquisition-related expenses, net of taxes, which have been reflected in the pro forma earnings above as if they had been incurred in 2014. These pro forma results have been prepared to reflect fair value adjustments to intangible assets and the related amortization expense, net of tax, from January 1, 2014, as well as the post-acquisition capital structure.

2014 Activity

The following unaudited pro forma summary presents consolidated information of the Company as if the Agriphar and CAS Acquisitions had occurred on January 1, 2013:



(amounts in millions)	Year Ended December 31, 2014		Year Ended December 31, 2013
Revenue	$	1,405.9	$	731.8
Net Income (Loss) attributable to Stockholders	46.4		(229.5		)